Safety and Immunogenicity of One Dose of Novartis' Meningococcal ACWY-CRM Vaccine and GlaxoSmithKline Biologicals' Meningococcal ACWY-TT Vaccine in Healthy Toddlers

Clinical trial NCT01994629 · COMPLETED

Trial details

NCT number: NCT01994629
Sponsor: Novartis Vaccines
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Meningococcal Disease

Start date: 2013-11-01
Primary completion: 2014-04-01
Enrollment: 202

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.